바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev
e-Submission

Vol.61 No.6
Citation Share

Syndrome of Inappropriate Secretion of Antidiuretic Hormone Followitng Adjuvant Chemotherapy wih Cisplatin plus Paclitaxel in Non-Small Cell Lung Cancer Patieif

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2006, v.61 no.6, pp.591-594















& (2006). Syndrome of Inappropriate Secretion of Antidiuretic Hormone Followitng Adjuvant Chemotherapy wih Cisplatin plus Paclitaxel in Non-Small Cell Lung Cancer Patieif. Tuberculosis & Respiratory Diseases, 61(6), 591-594.
  • Downloaded
  • Viewed
PDF Download

Abstract

We report a case of pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following adjuvant chemotherapy. A 51-year-old woman with stage IIIA adenocarcinoma received left lower lobe lobectomy in July, 2006. And then combination chemotherapy with paclitaxel and cisplatin was given to the patient. In five days after completion of second cycle of the chemotherapy, she visited emergency room because of general weakness and seizure. Her brain MRI was shown to be no evidence of brain metastasis. Serum sodium, urine and plasma osmolarities were 117mEq/L, 589 and 244mOsm/kg, respectively. She was improved with fluid restriction. Although occurrence of SIADH following chemotherapy is rare, physician should give an attention the potential for development of SIADH in the course of chemotherapyin non-small cell lung cancer patient. (Tuberc Respir Dis 2006; 61: 591-594)

keywords
Syndrome of inappropriate secretion of antidiuretic hormone, Chemotherapy, Non-small cell lung cancer, Seizure., Syndrome of inappropriate secretion of antidiuretic hormone, Chemotherapy, Non-small cell lung cancer, Seizure.

Reference

1.

(1986) The syndrome of inappropriate secretion of antidiuretic hormone(SIADH)in small- cell lung cancer,

2.

(1995) Syndrome of inappropriate secretion of antidiuretic hormone(SIADH)in malignant disease,

3.

(2005) Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety,

4.

(1995) Non-small-cell lung cancer with multiple paraneoplastic syndromes,

5.

(2004) Adenocarcinoma of lung presenting with dysgeusia,

6.

(2006) Unpleasant sweet taste:a symptom of SIADH caused by lung cancer,

7.

(2001) Syndrome of inappropriate secretion of ADH(SIADH)following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion,

8.

(2002) Syndrome of inappropriate secretion of antidiuretic hormone induced by intraarterial cisplatin chemotherapy,

9.

(1996) Syndrome of inappropriate secretion of antidiuretic hormone following intra-thoracic cisplatin,

10.

(1984) Syndrome of inappropriate antidiuretic hormone secretion due to treatment of lung cancer with cisplatin,

11.

(1991) Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung,

12.

(2000) Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer,

13.

(1983) Cisplatin-induced massive renal tubular failure with wastage of serum electrolytes,

14.

(1988) Renal salt wasting in patients treated with cisplatin,

15.

(2002) Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia:case report,

16.

Syndrome of inappropriate antidiuretic hormone secretion following dis- dichlorodiammineplatinum II in a patient with malignant thymoma,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy